Viewing Study NCT04521803


Ignite Creation Date: 2025-12-24 @ 7:21 PM
Ignite Modification Date: 2026-01-03 @ 10:58 PM
Study NCT ID: NCT04521803
Status: RECRUITING
Last Update Posted: 2025-08-21
First Post: 2020-07-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: High vs. Standard Dose Rifampicin for Effusive Tuberculous Pericarditis
Sponsor: University of Cape Town
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Tuberculous Pericarditis View
None HIV Status View
Keywords: